ARTICLES BY THIS AUTHOR
- 5/10/2012
Generic industry responds to latest Ontario drug reforms
The association representing Canada's generic manufacturers is demanding the provincial government backtrack on plans for further cuts to generic prescription drug prices. - 5/10/2012
Canadian generic drug makers push for greater global access
As trade negotiations continue with the EU, provinces and generics are wary of patent extensions - 5/10/2012
Preparing students for the business of pharmacy
The University of Alberta is taking the lead to ensure future pharmacists are fully prepared for the business of pharmacy. - 5/9/2012
NPs, midwives could get drug-prescribing powers in some provinces
Proposed changes to the Controlled Substances Act would allow midwives, nurse practitioners and foot specialists in some provinces to prescribe medications classified as controlled substances as soon as this fall. - 5/9/2012
Doctor group looks to renew democracy on BCMA board
A new campaign banner has emerged in this year’s British Columbia Medical Association elections. “B.C. Doctors for a Democratic Future” is an initiative to flag BMCA candidates who are seen as more likely to be pro-democracy. “Our message to doctors is, ‘Pay attention, engage and start making meaningful decisions or forever have health authorities and government do it for you.’” - 5/9/2012
CACDS appoints interim CEO
Ian McKinnon joins Canadian Association of Chain Drug Stores as interim CEO as Nadine Saby departs. - 5/9/2012
DINNER TONIGHT: Fresh grilled trout
- 5/9/2012
Why the OMA missed the boat in current negotiations with government
Playing the “access card” when some parts of the province are practically swarming with doctors is just plain bad strategy, and the fact is that in those areas where access continues to be a problem the OMA has proven powerless to convince their colleagues to serve. The OMA should have figured out months ago that the government had decided to make them a poster child for austerity. - 5/8/2012
MaRS, SickKids develop anti-scarring cream with Chinese drug firm
MaRS Innovation and The Hospital for Sick Children, both in Toronto, along with NovoTek Therapeutics Inc. of Beijing, China, have announced a strategic partnership to co-develop and bring to the Chinese market a novel therapeutic cream aimed at reducing scar formation following surgery.